UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predicting Effectiveness of Imatinib Mesylate in Tumors Expressing Platelet-Derived Growth Factors (PDGF-AA, PDGF-BB), Stem Cell Factor Ligands and Their Respective Receptors (PDGFR-α, PDGFR-β, and c-kit)

Journal of gastrointestinal cancer, 2015-09, Vol.46 (3), p.272-283

Moawad, Emad Y.

2015

Volltextzugriff (PDF)

Optimizing and predicting the in vivo activity of AT9283 as a monotherapy and in combination with paclitaxel

Journal of gastrointestinal cancer, 2015-12, Vol.46 (4), p.380-389

Moawad, Emad Y.

2015

Volltextzugriff (PDF)

Identifying the optimal dose of ritonavir in the treatment of malignancies

Metabolic brain disease, 2014-06, Vol.29 (2), p.533-540

Moawad, Emad Y.

2014

Volltextzugriff (PDF)

Reconciliation between the clinical and pathological staging of cancer

Comparative clinical pathology, 2014-03, Vol.23 (2), p.255-262

Moawad, Emad Y.

2014

Volltextzugriff (PDF)

Clinical and pathological staging of the cancer at the nanoscale

Cancer nanotechnology, 2012, Vol.3 (1-6), p.37-46

Moawad, Emad Y.

2012

Volltextzugriff (PDF)

Identifying and Predicting the Effectiveness of Carboplatin In Vivo and In Vitro and Evaluating its Combination with Paclitaxel

Indian journal of gynecologic oncology, 2015-12, Vol.13 (1), Article 1

Moawad, Emad Y.

2015

Volltextzugriff (PDF)

Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer

Molecular cancer therapeutics, 2018-01, Vol.17 (1), p.306-315

2018

Volltextzugriff (PDF)

Tubular Carcinoma of the Breast: Further Evidence to Support Its Excellent Prognosis

Journal of clinical oncology, 2010-01, Vol.28 (1), p.99-104

2010

Volltextzugriff (PDF)

PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers

Cancer letters, 2020-01, Vol.469, p.124-133

2020

Volltextzugriff (PDF)

Cancer and inflammation: promise for biologic therapy

Journal of immunotherapy (1997), 2010-05, Vol.33 (4), p.335-351

2010

Volltextzugriff (PDF)

RECQL4 helicase has oncogenic potential in sporadic breast cancers

The Journal of pathology, 2016-03, Vol.238 (4), p.495-501

2016

Volltextzugriff (PDF)

ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers

Gynecologic oncology, 2019-05, Vol.153 (2), p.416-424

2019

Volltextzugriff (PDF)

Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer

Molecular cancer therapeutics, 2015-04, Vol.14 (4), p.1057-1065

2015

Volltextzugriff (PDF)

Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program

Cancer research (Chicago, Ill.), 2018-05, Vol.78 (10), p.2524-2535

2018

Volltextzugriff (PDF)

The Value of Intraoperative Frozen Section Analysis for Margin Status in Breast Conservation Surgery in a Nontertiary Institution

International Journal of Breast Cancer, 2014-01, Vol.2014 (2014), p.170-176

2014

Volltextzugriff (PDF)

Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4060-4066

2013

Volltextzugriff (PDF)

Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations

The Journal of pathology, 2016-04, Vol.238 (5), p.677-688

2016

Volltextzugriff (PDF)

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy

Breast cancer research and treatment, 2018-06, Vol.169 (2), p.277-286

2018

Volltextzugriff (PDF)

Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer

Frontiers in oncology, 2021-07, Vol.11, p.695404-695404

2021

Volltextzugriff (PDF)

A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920930359-1758835920930359

2020

Volltextzugriff (PDF)

The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study

The Journal of pathology, 2015-10, Vol.237 (2), p.166-178

2015

Volltextzugriff (PDF)

Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers

NPJ breast cancer, 2021-11, Vol.7 (1), p.143-143, Article 143

2021

Volltextzugriff (PDF)

Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivo

Endocrine-related cancer, 2018-01, Vol.25 (1), p.99-109

2018

Volltextzugriff (PDF)

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)

Journal of clinical oncology, 2024-06, Vol.42 (18), p.2161

2024

Volltextzugriff (PDF)

Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers

Carcinogenesis (New York), 2016-01, Vol.37 (1), p.63-71

2016

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predicting Effectiveness of Imatinib Mesylate in Tumors Expressing Platelet-Derived Growth Factors (PDGF-AA, PDGF-BB), Stem Cell Factor Ligands and Their Respective Receptors (PDGFR-α, PDGFR-β, and c-kit)

Optimizing and predicting the in vivo activity of AT9283 as a monotherapy and in combination with paclitaxel

Identifying the optimal dose of ritonavir in the treatment of malignancies

Reconciliation between the clinical and pathological staging of cancer

Clinical and pathological staging of the cancer at the nanoscale

Identifying and Predicting the Effectiveness of Carboplatin In Vivo and In Vitro and Evaluating its Combination with Paclitaxel

Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer

Tubular Carcinoma of the Breast: Further Evidence to Support Its Excellent Prognosis

PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers

Cancer and inflammation: promise for biologic therapy

RECQL4 helicase has oncogenic potential in sporadic breast cancers

ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers

Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer

Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program

The Value of Intraoperative Frozen Section Analysis for Margin Status in Breast Conservation Surgery in a Nontertiary Institution

Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer

Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy

Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer

A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer

The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study

Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers

Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivo

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)

Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers

Aktive Filter

Suchergebnisse filtern